Skip to main content

MoneyWorks4Me

Cadila healthcare informs about press release

04 Mar 2020 Evaluate

Cadila healthcare has informed that the company has enclosed a copy of press release dated March 4, 2020 titled ‘Zydus receives final approval from the USFDA for Emtricitabine and Tenofovir disoproxil Fumarate Tablets 200 mg / 300 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..